跳至主要内容
临床试验/NCT03454269
NCT03454269Unknown不适用

Role of Retina in Mechanisms of Illusions and Visual Hallucinations Observed in Idiopathic Parkinson's Disease

University Hospital, Clermont-Ferrand1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2018年3月8日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
90
试验地点
1
主要终点
Total and segmental Retinal thickness (in microns) measured with Optical Coherence Tomography

研究概览

简要总结

Parkinson's disease is characterized not only by motor symptoms but also by psycho-behavioral symptoms including Visual Hallucinations (VH) and illusions (I), that are generally associated with a severe functional impairment and a bad prognosis for patients. Visual Hallucinations are defined by a visual perception without any real objet to perceive, whereas illusions are defined by a wrong perceptions of an object that is really present. In most of studies investigating the pathophysiology of VH in PD, no difference is made between VH and I, however different mechanisms could lead to the emergence of these two phenomenon, with different prognosis.

Investigator hypothesize that illusions could be related to a visual impairment, maybe at the retinal level, known to be impaired in PD, whereas Visual hallucinations would be due to a more widespread impairment affecting higher levels visuo-perceptive and cognitive functions.

详细描述

Parkinson's disease is a neurodegenerative disorder characterized by tremor, rigidity and akinesia, but patients can also present various non-motor symptoms in the course of their illness, including visual hallucinations, delusions or illusions. Visual Hallucinations are false perceptions (no external stimulus is present; generally caused by internal stimulations), whereas illusions are defined by a wrong perception (an external stimulus is always present). Delusions are false believes .The occurrence of hallucinations in PD is of major importance as it has been shown to be associated with an increased risk of cognitive impairment and could lead to nursing home placement and to increased mortality. It is generally believed that delusions/illusions also imply a bad prognosis with time . However recent data suggest that delusions/illusion are not associated with such a poor outcome regarding cognitive functions and mortality compared to hallucinations suggesting different pathological mechanisms and anatomical substrates . Also, a recent study analyzing the neuropsychological correlates of minor hallucinations in PD did not find executive dysfunction to contribute to the onset of minor psychotic phenomena, but was specifically implicated in the progression to well-structured VH.

Thus illusions and minorVH may have a different pathogenesis and a different prognosis compared to complex VH, however studies exploring the structural and functional changes associated with hallucinations in PD have mainly included patients with well-structured VH and moderate to severe cognitive impairment , making it difficult to define early abnormalities associated with minor hallucinations or illusions.

Several hypotheses are proposed regarding the emergence of hallucinations in PD.

  • It has been first suggested that hallucinations in PD could be mainly the result of a chronic exposition to dopaminergic therapy . However, the description of hallucination in untreated PD patients goes against that solely explication . Besides, no strong link has been identified between the occurrence of VH and the dosage and duration of dopaminergic treatment . This suggests that Dopaminergic treatment would not directly cause VH but could be a precipiting factor.
  • Sleep-wake cycle disturbances have also been reported as risk factors for the occurrence of VH in PD , and particularly the presence of REM Sleep behavior disorders (RBD) . The emergence of VH in PD patients coinciding with daytime episodes of REM sleep may be dream imagery occurring during wake , however this hypothesis is still debated.
  • Other risk factors have been associated with VH in PD such as the disease duration, motor symptom severity and mostly cognitive impairment. Indeed, VH occur mainly in PD patients with cognitive decline , but also VH are predictive of dementia . In fact, cognitive impairment in PD patients, and particularly visuoperceptive impairment, would lead to an impaired processing of visual information. Indeed, impaired frontal and parietal cortical activation have been reported in PD patients with VH while being presented visual stimulations, suggesting a diminished answer to external perceptions in posterior cortical areas associated with an increased frontal abnormal activity leading to the emergence of sensorial visual experiences . This shifting visual circuitry from posterior to anterior regions associated with attention process impairment may play a role in the pathophysiology of VH in PD. Thus, the occurrence of Visual Hallucinations in PD Patients appears to be due to a desinhibition of the "top-down" visual stream leading to the emergence of internal mental imagery stocked in memory, and interpreted like visual perceptions coming from the external environment .
  • Yet, some evidences also points out to an impaired "bottom-up" processing that could lead to the emergence of VH in PD. Indeed, a dopaminergic denervation and alpha synuclein aggregation have been demonstrated in the retina of PD Patients , even at early stages of the disease . However the functional consequences of such a denervation are still poorly understood , even if impaired contrast discrimination and color vision impairment are widely described in PD . One study has reported an association between retinal impairment, measured with OCT, and VH in PD .

Thus, the emergence of VH and illusions in PD could be due to an inbalance between a hypoactivated "bottom-up" (due to retino-striato-occipital hypoactivation) and a deshinibited "top-down" (mainly frontal) visual stream. However in all these studies, Hallucinations and illusions were not specifically discriminated and investigated in spite of the fact that they could be subtended by different pathophysiological mechanisms and might imply different prognosis for the evolution of the disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •- patients presenting with a Parkinson's Disease according to UKPDSBB criteria
  • •Patients affiliated to a health insurance company.
  • •HV-/IV+ Group : patients presenting illusions criteria according to SCOPA, with no visual hallucinations
  • •HV+/IV- Group : patients presenting visual hallucinations (SCOPA) without illusions
  • •HV-/IV- Group : patients without hallucinations or illusions SCOPA)

排除标准

  • •Patients with other neurological diseases than PD.
  • •Patients with active psychiatric pathologies (psychosis).
  • •Patients unable to remain sit and still during different ophtalmological exams due to camptocormia and dyskinesias.

研究组 & 干预措施

PD patients with visual hallucinations (PD-VH)

Active Comparator

PD patients without hallucinations or illusions

干预措施: Optical Coherence Tomography (Diagnostic Test)

Patients with illusions (PD-I)

Active Comparator

PD patients with Illusions and without hallucinations

干预措施: Optical Coherence Tomography (Diagnostic Test)

Patients without visual hallucinations or illusions (PD-nVHI))

Active Comparator

PD patients without Illusions and with hallucinations

干预措施: Optical Coherence Tomography (Diagnostic Test)

结局指标

主要结局

Total and segmental Retinal thickness (in microns) measured with Optical Coherence Tomography

时间窗: at day 15

Measurement of different retinal layers using Optical coherence tomography

次要结局

  • Contrast sensitivity measured using the Vistech test(at day 15)
  • Characteristics and severity of hallucinations/illusions using Psychosensory Hallucination Scale(at baseline)
  • Characteristics and severity of hallucinations/illusions measured using the University of Miami Parkinson's Disease Hallucinations Questionnaire(at baseline)
  • Cognitive function evaluated by the Montreal Cognitive Assessment(at day 15)
  • Dementia evaluated by the Mattis Dementia Rating Scale(at day 15)
  • Parkinsonian syndrome severity measured by the Hoehn and Yahr score(at day 15)
  • Volume of grey matter area (frontal , parietal, occipital, mesencephalic cortex area ) measured at the time of Magnetic Resonance Imaging(at day 15)
  • Emergence of Hallucinations/illusions and distress measured by heart rate variability(at day 15)
  • Best corrected visual acuity measured by Parinaud scale(at day 15)
  • Intraocular pressure measured with air pulse tonometer(at day 15)
  • Color vision measured using the Test 15 Hue de Farnsworth(at day 15)
  • Parkinsonian syndrome severity measured with the MDS UPDRS Scale(at day 15)
  • Sleep quality measured by the Parkinson's Disease Sleep Scale(at day 15)
  • Emergence of Hallucinations/illusions and distress measured by electro dermal recording(at day 15)
  • Emergence of Hallucinations/illusions and distress measured by self-evaluation of Stress questionnaire(at day 15)
  • Emergence of Hallucinations/illusions and distress measured by spy glasses questionnaire(at day 15)
  • Vigilance measurement and sleep Attack research using the Epworth test(at day 15)

研究者

发起方
University Hospital, Clermont-Ferrand
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验